These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27886815)

  • 1. Antiplatelet Therapy for Secondary Prevention After Acute Myocardial Infarction.
    Cavallari I; Bonaca MP
    Interv Cardiol Clin; 2017 Jan; 6(1):119-129. PubMed ID: 27886815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
    Udell JA; Bonaca MP; Collet JP; Lincoff AM; Kereiakes DJ; Costa F; Lee CW; Mauri L; Valgimigli M; Park SJ; Montalescot G; Sabatine MS; Braunwald E; Bhatt DL
    Eur Heart J; 2016 Jan; 37(4):390-9. PubMed ID: 26324537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients.
    Kirshner HS
    J Neurol; 2010 Nov; 257(11):1788-97. PubMed ID: 20652300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events.
    Frampton JE
    Drugs; 2015 May; 75(7):797-808. PubMed ID: 25895464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of vorapaxar as approved for clinical use in the United States.
    Magnani G; Bonaca MP; Braunwald E; Dalby AJ; Fox KA; Murphy SA; Nicolau JC; Oude Ophuis T; Scirica BM; Spinar J; Theroux P; Morrow DA
    J Am Heart Assoc; 2015 Mar; 4(3):e001505. PubMed ID: 25792124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet Therapy and Clinical Outcomes Following Myocardial Infarction Among Patients in a U.S. Employer-Based Insurance Database.
    Patel MD; Wu D; Chase MR; Mavros P; Heithoff K; Hanson ME; Simpson RJ
    J Manag Care Spec Pharm; 2017 Jun; 23(6):684-690. PubMed ID: 28530518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
    Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
    Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events.
    Lam S; Tran T
    Cardiol Rev; 2015; 23(5):261-7. PubMed ID: 25923910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction.
    Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Steg PG; Wiviott SD; Mauri L;
    J Am Coll Cardiol; 2016 May; 67(21):2492-502. PubMed ID: 27046159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis.
    Bohn B; Schöfl C; Zimmer V; Hummel M; Heise N; Siegel E; Karges W; Riedl M; Holl RW;
    Cardiovasc Diabetol; 2016 May; 15():72. PubMed ID: 27141979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent clinical trial results with antiplatelet therapy: implications in stroke prevention.
    Teal PA
    Cerebrovasc Dis; 2004; 17 Suppl 3():6-10. PubMed ID: 14730252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.
    Lettino M; Leonardi S; De Maria E; Halvorsen S
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):61-70. PubMed ID: 28618904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Ischemic Stroke: Strategies for Prevention.
    Oza R; Rundell K; Garcellano M
    Am Fam Physician; 2017 Oct; 96(7):436-440. PubMed ID: 29094912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy for secondary prevention in stroke � making the right choice.
    Ling G
    Curr Vasc Pharmacol; 2012 Mar; 10(2):225-37. PubMed ID: 22022772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.
    Xie W; Zheng F; Zhong B; Song X
    J Am Heart Assoc; 2015 Aug; 4(8):e002259. PubMed ID: 26304937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.